Kevin Waters - 05 Mar 2026 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
EVP, CFO
Signature
/s/ Jonathan Stone, Attorney-in-Fact for Kevin Waters
Issuer symbol
PRCT
Transactions as of
05 Mar 2026
Net transactions value
-$159,300
Form type
4
Filing time
09 Mar 2026, 17:40:49 UTC
Previous filing
25 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Waters Kevin EVP, CFO C/O PROCEPT BIOROBOTICS CORPORATION, 150 BAYTECH DRIVE, SAN JOSE /s/ Jonathan Stone, Attorney-in-Fact for Kevin Waters 09 Mar 2026 0001653771

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Award +47,462 +43% $0.000000* 158,985 05 Mar 2026 Direct F1
transaction PRCT Common Stock Sale $159,300 -6,721 -4.2% $23.70 152,264 06 Mar 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Stock Option (Right to Buy) Award +32,576 $0.000000* 32,576 05 Mar 2026 Common Stock 32,576 $25.35 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2027, with onesixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date.
F2 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units and Performance Stock Units.
F3 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.